लोड हो रहा है...
Oral 5‐aminosalicylic acid for maintenance of remission in ulcerative colitis
BACKGROUND: Oral 5‐aminosalicylic acid (5‐ASA; also known as mesalazine or mesalamine) preparations were intended to avoid the adverse effects of sulfasalazine (SASP) while maintaining its therapeutic benefits. In an earlier version of this review, we found that 5‐ASA drugs were more effective than...
में बचाया:
| में प्रकाशित: | Cochrane Database Syst Rev |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
John Wiley & Sons, Ltd
2020
|
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8094989/ https://ncbi.nlm.nih.gov/pubmed/32856298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD000544.pub5 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|